William Blair


William Blair Initiates Coverage On Allison Transmission Holdings, Sets $36 Price Target

In a research note released this afternoon, William Blair analyst Lawrence De Maria initiated coverage on Allison Transmission Holdings, Inc. (ALSN) with an Outperform rating and …

We Believe Oracle Shares Trade Roughly At Fair Value, Says William Blair

In a research note released today, William Blair analyst Jason Ader reiterated coverage on Oracle Corporation (ORCL) with a Market Perform rating following soft fiscal 2014 …

CarMax: William Blair Ups To Outperform; Believes The Reward Scenario Is Now Greatly Improved

William Blair analyst Sharon Zackfia today upgraded her rating on CarMax Inc. (KMX) to Outperform from Market Perform following a strong first-quarter earnings report.

William Blair Downgrades Coach To Market Perform; Prefers To Move To The Sidelines

In a research report released today, William Blair analyst Amy Noblin downgraded the rating on Coach, Inc. (COH) to “Market Perform” from “Outperform”.

William Blair Maintains Outperform On IHS Following Q2 Results

In a research note published this morning, William Blair analyst Brandon Dobell maintained coverage with an “Outperform” rating on IHS Inc. (IHS) following IHS’s second quarter 2014 results, which were better than expected.

William Blair Maintains Outperform On TESSCO Technologies Following Discussions With Executives

In a research report issued this morning, William Blair analyst Anil Doradla maintained coverage with a “Market Perform” rating on TESSCO Technologies Incorporated (TESS) following discussions he has held with …

Medtronic Upgraded To Outperform From Market Perform At William Blair

Analyst Ben Andrew of William Blair upgraded Medtronic, Inc. (MDT) from Market Perform to Outperform in a research report released on today.

William Blair Reiterates Outperform On Encore Capital

In a research note released today, William Blair reiterated coverage on Encore Capital Group, Inc (ECPG) with an Outperform rating. Blair analyst Robert Napoli has increased confidence in Encore’s long-term growth …

William Blair Maintains Outperform On BioDelivery Sciences

William Blair today maintained an Outperform rating on BioDelivery Sciences (BDSI) with $23.00 price target, which is derived through a net present value analysis …

William Blair Reiterates Outperform Rating For Dynavax

In a research note released this morning, William Blair reiterated coverage on Dynavax Technologies Corporation (DVAX) with an Outperform rating and a price target of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts